Active Ingredient(s): Delafloxacin
FDA Approved: * June 19, 2017
Category: Antibiotics

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Baxdela Overview

Delafloxacin sold under the brand name Baxdela among others, is a fluoroquinolone antibiotic used to treat acute bacterial skin and skin structure infections.[1] Contents 1 Medical use 2 Adverse effects 3 Interactions 4 Pharmacology 5 Chemistry 6 History 7 References 8 External links Medical use Delafloxacin is indicated to treat adults with acute bacterial skin and skin structure infections (ABSSSI) caused by designated susceptible bacteria or adults with community-acq...

Read more Baxdela Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Baxdela Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Injection: 300mg
  • Powder: 300mg/vial
  • Tablet: 450mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Baxdela: (2 results)

Sorted by National Drug Code
  • 70842-101 Baxdela 450 mg Oral Tablet by Melinta Therapeutics, Inc
  • 70842-102 Baxdela 300 mg/10.5ml Intravenous Injection, Powder, Lyophilized, for Solution by Melinta Therapeutics, Inc

Other drugs which contain Delafloxacin or a similar ingredient: (1 result)